Acentra Health CEO Todd Stottlemyer Named to Virginia Business Magazine’s ‘500 Power List’ of Most Influential Leaders
03 Septiembre 2024 - 8:47AM
Acentra Health, a technology and health solutions and services
company dedicated to accelerating better outcomes for government
healthcare agencies and the priority populations they serve,
announced today that Virginia Business Magazine has named CEO Todd
Stottlemyer to its 2024 Virginia 500 Power List, which recognizes
the commonwealth’s most powerful and influential leaders in
business, government, and education. This is the third year in a
row he has been named to the Virginia 500 Power List.
"I am deeply honored to be recognized by Virginia Business
Magazine and to be included among such an esteemed group of
Virginia leaders," said Stottlemyer. "As a global company with
headquarters in Northern Virginia, Acentra Health and its more than
3,200 employees share a passion for innovating technology-based
health solutions and services that are improving the lives of
people in every state across the nation. Virginia is continually
recognized as one of the best places to do business, and we are
fortunate to call it home."
Acentra Health develops and deploys health technology solutions
and services that help government health agencies improve outcomes
for the priority populations they serve. Its work drives efficiency
and cost savings across 45 states and 25 federal agencies. Since
2007, the company has served as a vital partner to Virginia’s
Department of Medical Assistance Services (DMAS) providing
utilization management services for 2 million Virginians who access
their healthcare through the commonwealth’s Cardinal Care Medicaid
program. In 2023, DMAS extended its partnership with Acentra
Health, awarding a new five-year contract that expanded the
company’s scope of work to include service authorizations for
behavioral health services.
A Northern Virginia resident, Stottlemyer has led multiple
Virginia-based businesses in the technology and healthcare sectors,
contributing to the economic development of the region. Since
joining Acentra Health as CEO in 2018, he has overseen multiple
acquisitions that have expanded the company’s capabilities and more
than doubled its global workforce, which includes more than 300
employees in the Virginia, Maryland, Washington D.C., metro area.
He currently serves as vice chair of the Virginia Growth and
Opportunity (GO) Board and on the executive committee of the
Northern Virginia Technology Council, and serves on multiple other
boards, including the Wolf Trap Foundation for the Performing Arts.
A passionate advocate for hunger relief and education, Stottlemyer
was recognized in 2023 by No Kid Hungry as a Champion for
galvanizing Northern Virginia technology leaders in raising over $1
million to fight childhood hunger during the pandemic while kids
were learning from home.
According to Virginia Business, 500 Power List honorees are
selected, not nominated, by the magazine’s editorial staff
following an extensive review of Virginia executives across 20
industries throughout the commonwealth. The full list is available
at Virginia Business Magazine.
About Acentra Health
Acentra Health combines public sector knowledge, clinical
expertise, and technological ingenuity to modernize the healthcare
experience for state and federal partners and their priority
populations. From designing and developing advanced claims,
encounter, and provider solutions that drive efficiency and cost
savings to delivering clinically focused service models for care
management and quality oversight, Acentra Health is accelerating
better health outcomes. Acentra Health is backed by Carlyle
(NASDAQ: CG), a global investment firm. Learn more at
acentra.com.
Media Contact:Janice MooreVice President,
Corporate Communications703-214-3552
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d0e1c854-237f-45ed-82ed-d5caae425424
Carlyle (NASDAQ:CG)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Carlyle (NASDAQ:CG)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024